Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3. (Q41550210)

3 October 2017

Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3. (English)

1 reference

3 October 2017

1 reference

8

Darren C Tomlinson

0 references

Michael J. McPherson

7

object named as

Michael J McPherson

0 references

Christian Tiede

object named as

Christian Tiede

2

0 references

author name string

Chunmei Xie

1

1 reference

3 October 2017

Xuanyi Zhang

3

1 reference

3 October 2017

Congrong Wang

4

1 reference

3 October 2017

Zhixiong Li

5

1 reference

3 October 2017

Xiao Xu

6

1 reference

3 October 2017

Weiwen Xu

9

1 reference

3 October 2017

language of work or name

English

0 references

publication date

29 August 2017

1 reference

full work available at URL

3 October 2017

http://eprints.whiterose.ac.uk/120889/

content deliverer

White Rose Research Online

0 references

published in

Scientific Reports

1 reference

3 October 2017

7

1 reference

3 October 2017

1

1 reference

3 October 2017

9608

1 reference

Creative Commons Attribution 4.0 International

3 October 2017

start time

29 August 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Affimer proteins are versatile and renewable affinity reagents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Phage display-derived human antibodies in clinical development and therapy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Label-free electrochemical impedance biosensor to detect human interleukin-8 in serum with sub-pg/ml sensitivity.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Synergy of β-Lactams with Vancomycin against Methicillin-Resistant Staphylococcus aureus: Correlation of Disk Diffusion and Checkerboard Methods

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Diagnosis accuracy of serum Glypican-3 level in patients with hepatocellular carcinoma and liver cirrhosis: a meta-analysis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Exploration of the HIF-1α/p300 interface using peptide and Adhiron phage display technologies

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Diagnosis and treatment of hepatocellular carcinoma: An update

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: a systematic review and meta-analysis.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Preparation and characterization of monoclonal antibody against glypican-3.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

A proposal for validation of antibodies.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Antibody mimetic receptor proteins for label-free biosensors.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5575301

Glypican-3 as a serum marker for hepatocellular carcinoma

19 August 2018

1 reference

https://api.crossref.org/works/10.1038/S41598-017-10083-W

7 January 2021

Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling

1 reference

https://api.crossref.org/works/10.1038/S41598-017-10083-W

7 January 2021

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41598-017-10083-W

7 January 2021

Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41598-017-10083-W

7 January 2021

Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41598-017-10083-W

7 January 2021

[Evidence-based practice guidelines for standardized pathological diagnosis of primary liver cancer in China: 2015]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28852111

12 December 2020

inferred from PubMed ID database lookup

Guidelines on the diagnosis and treatment of primary liver cancer (2011 edition)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28852111

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/S41598-017-10083-W

1 reference

10.1038/S41598-017-10083-W

3 October 2017

0 references

Dimensions Publication ID

0 references

1 reference

3 October 2017

PubMed publication ID

28852111

1 reference